News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
707,615 Results
Type
Article (41917)
Company Profile (333)
Press Release (665365)
Section
Business (210166)
Career Advice (2080)
Deals (36583)
Drug Delivery (100)
Drug Development (82854)
Employer Resources (171)
FDA (16491)
Job Trends (15360)
News (355493)
Policy (33832)
Tag
Academia (2574)
Alliances (51188)
Alzheimer's disease (1280)
Approvals (16452)
Artificial intelligence (158)
Bankruptcy (362)
Best Places to Work (11716)
Biotechnology (215)
Breast cancer (193)
Cancer (1402)
Cardiovascular disease (116)
Career advice (1741)
Cell therapy (286)
Clinical research (66252)
Collaboration (498)
Compensation (267)
COVID-19 (2613)
C-suite (111)
Data (1406)
Diabetes (179)
Diagnostics (6255)
Earnings (86580)
Employer resources (149)
Events (112879)
Executive appointments (405)
FDA (17190)
Funding (439)
Gene therapy (206)
GLP-1 (633)
Government (4453)
Healthcare (18879)
Infectious disease (2706)
Inflammatory bowel disease (115)
Interviews (320)
IPO (16623)
Job creations (4052)
Job search strategy (1488)
Layoffs (439)
Legal (8329)
Lung cancer (200)
Lymphoma (100)
Manufacturing (216)
Medical device (13300)
Medtech (13305)
Mergers & acquisitions (20122)
Metabolic disorders (479)
Neuroscience (1614)
NextGen Class of 2024 (6625)
Non-profit (4515)
Northern California (1711)
Obesity (272)
Opinion (207)
Patents (124)
People (58425)
Phase I (20521)
Phase II (29150)
Phase III (21860)
Pipeline (517)
Postmarket research (2651)
Preclinical (8730)
Radiopharmaceuticals (241)
Rare diseases (276)
Real estate (6241)
Regulatory (22529)
Research institute (2359)
Resumes & cover letters (358)
Southern California (1479)
Startups (3712)
United States (15446)
Vaccines (583)
Weight loss (197)
Date
Today (2)
Last 7 days (257)
Last 30 days (2194)
Last 365 days (35793)
2024 (35717)
2023 (40630)
2022 (51797)
2021 (56329)
2020 (54794)
2019 (47400)
2018 (35771)
2017 (33137)
2016 (32662)
2015 (38615)
2014 (32516)
2013 (27630)
2012 (29729)
2011 (30487)
2010 (28497)
Location
Africa (776)
Arizona (203)
Asia (40154)
Australia (6423)
California (3863)
Canada (1467)
China (317)
Colorado (176)
Connecticut (181)
Europe (85490)
Florida (540)
Georgia (136)
Illinois (397)
Indiana (233)
Maryland (642)
Massachusetts (3025)
Michigan (177)
Minnesota (293)
New Jersey (1125)
New York (1100)
North Carolina (761)
Northern California (1711)
Ohio (146)
Pennsylvania (936)
South America (1158)
Southern California (1479)
Texas (565)
Utah (109)
Washington State (408)
707,615 Results for "reviva pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Reviva Announces Proposed Public Offering
December 17, 2024
·
4 min read
Biotech Bay
Reviva to Participate in the BIO International Convention 2024
Reviva Pharmaceuticals Holdings, Inc. announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva will participate in a panel discussion at the BIO International Convention, taking place June 3-6, 2024, in San Diego, CA.
May 21, 2024
·
1 min read
Biotech Bay
Reviva Pharmaceuticals to Present at the 2024 BIO CEO & Investor Conference
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”) today announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva will present at the 2024 BIO CEO & Investor Conference, taking place February 26-27, 2024, in New York, NY.
February 20, 2024
·
1 min read
Business
Reviva Reports First Quarter 2024 Financial Results and Recent Business Highlights
Reviva Pharmaceuticals Holdings, Inc. today reported financial results for the first quarter ended March 31, 2024 and summarized recent business highlights.
May 14, 2024
·
9 min read
Press Releases
Reviva Announces Pricing of $18.0 Million Public Offering of Common Stock and Warrants
December 18, 2024
·
5 min read
Biotech Bay
Reviva to Present New Non-Clinical Pharmacology Data on Brilaroxazine at the ASPET 2024 Annual Meeting
Reviva Pharmaceuticals Holdings, Inc. announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva will present new pharmacology data on brilaroxazine as part of two poster presentations at the ASPET 2024 Annual Meeting, to be held in Arlington, VA May 16-19, 2024.
May 9, 2024
·
5 min read
Biotech Bay
Reviva to Present at the UBS Virtual CNS Day
Reviva Pharmaceuticals Holdings, Inc. announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva will participate in a Fireside Chat at the UBS Virtual CNS Day, taking place virtually March 18, 2024.
March 11, 2024
·
1 min read
Press Releases
Reviva to Participate in the UBS Global Healthcare Conference
October 31, 2024
·
1 min read
Press Releases
Reviva Pharmaceuticals to Participate in the Lytham Partners Fall 2024 Investor Conference
September 27, 2024
·
1 min read
Biotech Beach
Reviva Announces Enrollment Update for Open Label Extension Study Evaluating Brilaroxazine in Schizophrenia
Reviva Pharmaceuticals Holdings, Inc. today announced an enrollment update to the ongoing 1-year open-label extension (OLE) study evaluating the long-term safety and tolerability of brilaroxazine in patients with schizophrenia.
May 15, 2024
·
6 min read
1 of 70,762
Next
